Literature DB >> 17156159

A relative resistance of T cells to dexamethasone in bipolar disorder.

Esther M Knijff1, M Nadine Breunis, Marielle C van Geest, Ralph W Kupka, Cindy Ruwhof, Harm J de Wit, Willem A Nolen, Hemmo A Drexhage.   

Abstract

OBJECTIVE: A relative resistance of immune cells to steroids has been established in patients with major depression (MD). In this study, we investigated the in vitro responsiveness of T cells to dexamethasone (DEX) of patients with bipolar disorder (BD).
METHODS: T cells of outpatients with DSM-IV BD (n = 54) and of healthy control subjects (HC; n = 29) were isolated, cultured and stimulated with phytohemagglutinin (PHA) for 72 h. The suppressive effect of graded concentrations of DEX (5 x 10(-9)-10(-5) M) on PHA-induced CD25 (IL-2R) expression was measured by fluorescence-activated cell sorting (FACS) analysis. Data were correlated to the T-cell activation status in the peripheral blood of the same patients and to their diagnosis, current mood state, ultradian cycling pattern and current use of medication, including lithium.
RESULTS: T cells of patients with BD were less sensitive to DEX-induced suppressive effects as compared with T cells of HC. These data were particularly evident at 10(-7) M DEX (mean % suppression +/- SEM BD: 18.9% +/- 3.5 versus HC: 35.8% +/- 4.7, p = 0.001). We found no correlations of this relative in vitro DEX resistance of T cells neither with the previously mentioned clinical characteristics nor with the actual activation status of the T cells in the BD patients.
CONCLUSION: A relative T-cell resistance to steroids, as has been observed in MD previously, may be a trait phenomenon of BD, independent of mood state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156159     DOI: 10.1111/j.1399-5618.2006.00359.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  13 in total

1.  Evidence for Immune Activation and Resistance to Glucocorticoids Following Childhood Maltreatment in Adolescents Without Psychopathology.

Authors:  Carine Hartmann do Prado; Rodrigo Grassi-Oliveira; Ledo Daruy-Filho; Andréa Wieck; Moisés Evandro Bauer
Journal:  Neuropsychopharmacology       Date:  2017-06-30       Impact factor: 7.853

Review 2.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

3.  Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Katelyn A Collinger; Francis Lotrich; Anna L Marsland; Mary-Kay Gill; David A Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-10       Impact factor: 2.576

Review 4.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

Review 5.  The immunology of bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Jair C Soares; Antonio L Teixeira
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

6.  Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication.

Authors:  Jess G Fiedorowicz; Jill M Cyranowski; Zhuangzhuang Liu; Holly A Swartz
Journal:  Neurol Psychiatry Brain Res       Date:  2019-08-10

7.  Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation.

Authors:  Lucy Baldeón R; Karin Weigelt; Harm de Wit; Behiye Ozcan; Adri van Oudenaren; Fernando Sempértegui; Eric Sijbrands; Laura Grosse; Anton-Jan van Zonneveld; Hemmo A Drexhage; Pieter J M Leenen
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

Review 8.  The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.

Authors:  Helena Kyunghee Kim; Wenjun Chen; Ana Cristina Andreazza
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

9.  Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.

Authors:  Izabela Guimarães Barbosa; Natália Pessoa Rocha; Frankcinéia Assis; Érica Leandro Marciano Vieira; Jair C Soares; Moises Evandro Bauer; Antônio Lúcio Teixeira
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

10.  Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder.

Authors:  L A Carvalho; V Bergink; L Sumaski; J Wijkhuijs; W J Hoogendijk; T K Birkenhager; H A Drexhage
Journal:  Transl Psychiatry       Date:  2014-01-14       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.